A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

Autor: Hertzel C. Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Gilles R. Dagenais, Edward Franek, Mark Lakshmanan, Fernando Lanas, Lawrence A. Leiter, Nana Pogosova, Jeffrey Probstfield, Peter J. Raubenheimer, Matthew Riddle, Jonathan Shaw, Wayne H.-H. Sheu, Theodora Temelkova-Kurktschiev, Ibrahim Turfanda, Denis Xavier

Publikováno v: Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)

Abstract Background The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk.

Externí odkaz: https://doaj.org/article/d7e83d72a5384fcfbe6664e1096dbb38

A hybrid automated event adjudication system for clinical trials

Autor: Fei Yuan, Jackie Bosch, John Eikelboom, Gilles R Dagenais, Stuart Connolly, Jane Belanger, Tamara Marsden, Cissy Tang, Balakumar Swaminathan, Martin Renters, Leanne Dyal, Shrikant I Bangdiwala

Publikováno v: Clinical Trials. 20:166-175

Introduction: In clinical trials, event adjudication is a process to review and confirm the accuracy of outcomes reported by site investigators. Despite efforts to automate the communication between a clinical-data-and-coordination center and an even

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5faf695fce6010d71fe9353472ee6a2a
https://doi.org/10.1177/17407745221149222

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Autor: Stephen Kaptoge, Lisa Pennells, Dirk De Bacquer, Marie Therese Cooney, Maryam Kavousi, Gretchen Stevens, Leanne Margaret Riley, Stefan Savin, Taskeen Khan, Servet Altay, Philippe Amouyel, Gerd Assmann, Steven Bell, Yoav Ben-Shlomo, Lisa Berkman, Joline W Beulens, Cecilia Björkelund, Michael Blaha, Dan G Blazer, Thomas Bolton, Ruth Bonita Beaglehole, Hermann Brenner, Eric J Brunner, Edoardo Casiglia, Parinya Chamnan, Yeun-Hyang Choi, Rajiv Chowdry, Sean Coady, Carlos J Crespo, Mary Cushman, Gilles R Dagenais, Ralph B D'Agostino Sr, Makoto Daimon, Karina W Davidson, Gunnar Engström, Ian Ford, John Gallacher, Ron T Gansevoort, Thomas Andrew Gaziano, Simona Giampaoli, Greg Grandits, Sameline Grimsgaard, Diederick E Grobbee, Vilmundur Gudnason, Qi Guo, Hanna Tolonen, Steve Humphries, Hiroyasu Iso, J Wouter Jukema, Jussi Kauhanen, Andre Pascal Kengne, Davood Khalili, Wolfgang Koenig, Daan Kromhout, Harlan Krumholz, TH Lam, Gail Laughlin, Alejandro Marín Ibañez, Tom W Meade, Karel G M Moons, Paul J Nietert, Toshiharu Ninomiya, Børge G Nordestgaard, Christopher O'Donnell, Luigi Palmieri, Anushka Patel, Pablo Perel, Jackie F Price, Rui Providencia, Paul M Ridker, Beatriz Rodriguez, Annika Rosengren, Ronan Roussel, Masaru Sakurai, Veikko Salomaa, Shinichi Sato, Ben Schöttker, Nawar Shara, Jonathan E Shaw, Hee-Choon Shin, Leon A Simons, Eleni Sofianopoulou, Johan Sundström, Henry Völzke, Robert B Wallace, Nicholas J Wareham, Peter Willeit, David Wood, Angela Wood, Dong Zhao, Mark Woodward, Goodarz Danaei, Gregory Roth, Shanthi Mendis, Oyere Onuma, Cherian Varghese, Majid Ezzati, Ian Graham, Rod Jackson, John Danesh, Emanuele Di Angelantonio

Publikováno v: The Lancet Global Health, Vol 7, Iss 10, Pp e1332-e1345 (2019)

Summary: Background: To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, valid

Externí odkaz: https://doaj.org/article/cbe6b4445261496287e2ed04c8f32089

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Autor: Adrianna Murphy, PhD, Benjamin Palafox, MSc, Owen O'Donnell, ProfPhD, David Stuckler, ProfPhD, Pablo Perel, PhD, Khalid F AlHabib, ProfMBBS, Alvaro Avezum, ProfPhD, Xiulin Bai, BSc, Jephat Chifamba, ProfDPhil, Clara K Chow, ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, Roya Kelishadi, MD, Rasha Khatib, PhD, Fernando Lanas, PhD, Scott A Lear, ProfPhD, Wei Li, ProfPhD, Jia Liu, MSc, Patricio Lopez-Jaramillo, ProfPhD, Viswanathan Mohan, ProfMD, Nahed Monsef, PhD, Prem K Mony, MD, Thandi Puoane, ProfDrPH, Sumathy Rangarajan, MSc, Annika Rosengren, ProfMD, Aletta E Schutte, ProfPhD, Mariz Sintaha, MSc, Koon K Teo, ProfPhD, Andreas Wielgosz, ProfMD, Karen Yeates, MD, Lu Yin, PhD, Khalid Yusoff, ProfMBBS, Katarzyna Zatońska, PhD, Salim Yusuf, ProfPhD, Martin McKee, ProfPhD

Publikováno v: The Lancet Global Health, Vol 6, Iss 3, Pp e292-e301 (2018)

Summary: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, choleste

Externí odkaz: https://doaj.org/article/d48fe3873f824d4ca3b3e34e4f9ab7f6

The cost-effectiveness of Rivaroxaban with or without aspirin in the COMPASS trial

Autor: Andre Lamy, John Eikelboom, Wesley Tong, Fei Yuan, Shrikant I Bangdiwala, Jackie Bosch, Stuart Connolly, Eva Lonn, Gilles R Dagenais, Kelley R H Branch, Wei-Jhih Wang, Deepak L Bhatt, Jeff Probstfield, Georg Ertl, Stefan Störk, P Gabriel Steg, Victor Aboyans, Isabelle Durand-Zaleski, Lars Ryden, Salim Yusuf

Publikováno v: European heart journal. Quality of careclinical outcomes.

Aims The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial demonstrated that rivaroxaban 2.5 mg BID with aspirin 100 mg was more effective than aspirin 100 mg daily alone for the prevention of cardiovascular (CV) dea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06db07d18dddf7939391120530012450
https://pubmed.ncbi.nlm.nih.gov/36001989